相似文献
1
Mapping the spread of malaria drug resistance.
PLoS Med. 2009 Apr 14;6(4):e1000054. doi: 10.1371/journal.pmed.1000054.
2
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.
PLoS Med. 2009 Apr 14;6(4):e1000055. doi: 10.1371/journal.pmed.1000055.
3
Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru.
Antimicrob Agents Chemother. 2008 Feb;52(2):739-41. doi: 10.1128/AAC.00975-07. Epub 2007 Nov 19.
4
High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Malar J. 2019 Mar 26;18(1):101. doi: 10.1186/s12936-019-2734-x.
5
More on 'the efficacy of antifolate antimalarial combinations in Africa'.
Parasitol Today. 1999 Apr;15(4):131-2. doi: 10.1016/s0169-4758(99)01419-2.
6
Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Infect Genet Evol. 2009 Sep;9(5):778-83. doi: 10.1016/j.meegid.2009.04.010. Epub 2009 Apr 18.
7
Molecular analysis of chloroquine and sulfadoxine-pyrimethamine resistance-associated alleles in Plasmodium falciparum isolates from Nicaragua.
Am J Trop Med Hyg. 2014 May;90(5):840-5. doi: 10.4269/ajtmh.13-0214. Epub 2014 Mar 10.
8
Selection and synergy in Plasmodium falciparum.
Parasitol Today. 1999 Apr;15(4):132-4. doi: 10.1016/s0169-4758(99)01420-9.
9
A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
J Clin Microbiol. 2007 Mar;45(3):752-61. doi: 10.1128/JCM.01683-06. Epub 2006 Nov 22.
10
Emergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decades.
Infect Genet Evol. 2015 Dec;36:190-198. doi: 10.1016/j.meegid.2015.08.027. Epub 2015 Aug 28.
引用本文的文献
1
In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Malar J. 2020 Jan 6;19(1):8. doi: 10.1186/s12936-019-3089-z.
2
3
Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change.
Malar J. 2014 May 31;13:207. doi: 10.1186/1475-2875-13-207.
4
Proposal for a new therapy for drug-resistant malaria using Plasmodium synthetic lethality inference.
Int J Parasitol Drugs Drug Resist. 2013 Jun 28;3:119-28. doi: 10.1016/j.ijpddr.2013.06.001. eCollection 2013 Dec.
5
Genetics of chloroquine-resistant malaria: a haplotypic view.
Mem Inst Oswaldo Cruz. 2013 Dec;108(8):947-61. doi: 10.1590/0074-0276130274.
6
A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India.
Malar J. 2013 Jul 17;12:247. doi: 10.1186/1475-2875-12-247.
7
Host resistance, population structure and the long-term persistence of bubonic plague: contributions of a modelling approach in the Malagasy focus.
PLoS Comput Biol. 2013;9(5):e1003039. doi: 10.1371/journal.pcbi.1003039. Epub 2013 May 9.
8
Mobile phones and malaria: modeling human and parasite travel.
Travel Med Infect Dis. 2013 Jan-Feb;11(1):15-22. doi: 10.1016/j.tmaid.2012.12.003. Epub 2013 Mar 9.
9
Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.
Am J Trop Med Hyg. 2011 Jul;85(1):34-41. doi: 10.4269/ajtmh.2011.10-0674.
10
Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.
BMC Syst Biol. 2010 Aug 31;4:120. doi: 10.1186/1752-0509-4-120.
本文引用的文献
1
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.
PLoS Med. 2009 Apr 14;6(4):e1000055. doi: 10.1371/journal.pmed.1000055.
2
BeadArray-based genotyping.
Methods Mol Biol. 2008;439:53-74. doi: 10.1007/978-1-59745-188-8_4.
3
Genetic linkage and association analyses for trait mapping in Plasmodium falciparum.
Nat Rev Genet. 2007 Jul;8(7):497-506. doi: 10.1038/nrg2126.
4
The origins and spread of antimalarial drug resistance: lessons for policy makers.
Acta Trop. 2005 Jun;94(3):269-80. doi: 10.1016/j.actatropica.2005.04.010.
5
Mechanisms of resistance of malaria parasites to antifolates.
Pharmacol Rev. 2005 Mar;57(1):117-45. doi: 10.1124/pr.57.1.4.
6
The origins of antimalarial drug resistance.
Trends Parasitol. 2004 Nov;20(11):512-8. doi: 10.1016/j.pt.2004.08.006.
7
Genetic and biochemical aspects of drug resistance in malaria parasites.
Curr Drug Targets Infect Disord. 2004 Mar;4(1):1-10. doi: 10.2174/1568005043480925.
8
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.
J Infect Dis. 2003 Jun 15;187(12):1870-5. doi: 10.1086/375419. Epub 2003 May 21.
9
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
J Infect Dis. 2002 Feb 1;185(3):380-8. doi: 10.1086/338566. Epub 2002 Jan 17.
10
Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum.
Mol Biol Evol. 2000 Oct;17(10):1467-82. doi: 10.1093/oxfordjournals.molbev.a026247.
Zotero 插件